BC
GH icon

Brookfield Corp’s Guardant Health GH Stock Holding History

Brookfield Corp’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-29,927
Closed -$1.61M – 649
2022
Q3 		$1.61M Buy
29,927
+22,257
+290% +$1.14M 0.01% 488
2022
Q2 		$309K Sell
7,670
-27,945
-78% -$1.38M ﹤0.01% 550
2022
Q1 		$2.36M Buy
+35,615
New +$2.44M 0.01% 369
2020
Q3 		– Sell
-25,000
Closed -$2.03M – 412
2020
Q2 		$2.03M Buy
+25,000
New +$2.01M 0.01% 219

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Brookfield Corp's GH Position: Q4 2022 in Review

Brookfield Corp sold out of Guardant Health (GH) in Q4 2022, closing a stake of 29,927 shares — an estimated $1.61M sold.

Brookfield Corp first reported a position in GH in Q2 2020 and held it in 4 quarters. The position peaked at $2.36M in Q1 2022. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • Brookfield Corp reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
  • Brookfield Corp sold 29,927 Guardant Health shares in Q4 2022, an estimated $1.61M.
  • Brookfield Corp first reported a position in Guardant Health in Q2 2020 and held it in 4 quarters.
  • Brookfield Corp's Guardant Health position peaked at $2.36M in Q1 2022.
  • 290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on Brookfield Corp's 13F filing for Q4 2022, filed 14 Feb 2023.